| NCT05597462 | Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks | COMPLETED | PHASE1 | 2022-09-30 | 2023-05-30 | 2023-05-30 |
| NCT05452785 | A Comparative Bioavailability Study of DFD-29 Capsules 40 mg Versus SOLODYN® Tablets 105 mg, Under Fasting & Fed Conditions in Healthy Adult Human Subjects | COMPLETED | PHASE1 | 2022-05-07 | 2022-05-25 | 2022-05-25 |
| NCT05343455 | A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2) | COMPLETED | PHASE3 | 2022-03-29 | 2023-06-30 | 2023-06-30 |
| NCT05296629 | A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea. | COMPLETED | PHASE3 | 2022-03-14 | 2023-06-30 | 2023-06-30 |
| NCT03880266 | A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis | COMPLETED | PHASE2 | 2019-02-22 | 2019-05-24 | 2019-05-24 |
| NCT02530294 | Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis | COMPLETED | PHASE3 | 2015-08 | 2016-04 | 2016-04 |
| NCT02553798 | Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis | COMPLETED | PHASE3 | 2015-08 | 2016-12 | 2016-12 |
| NCT02530281 | Study of Glycopyrronium in Axillary Hyperhydrosis | COMPLETED | PHASE3 | 2015-07 | 2016-03 | 2016-03 |
| NCT02129660 | Comparator Study of the Effect of Glycopyrrolate and Glycopyrronium in Subjects With Axillary Hyperhidrosis | COMPLETED | PHASE2 | 2014-04 | 2015-01 | 2015-01 |
| NCT02016885 | A Dose-Ranging Study of the Effect of Glycopyrrolate in Subjects With Axillary Hyperhidrosis | COMPLETED | PHASE2 | 2013-11 | 2014-09 | 2014-09 |